Ironwood Pharmaceuticals Inc (IRWD) saw downtrend of -1.15% in the recent trading with $8.61 being its most recent. The current price level -45.16% lower than the highest price of $15.70 marked by the stock while trading over the past 52-weeks, whereas it is 6.63% higher than the lowest price of $8.07 the company dropped to over past 52-weeks. The latest news story on IRWD appeared in (Business Wire) under the title “Ironwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)”.
Squeezing the time span to 30 day period shows us the stock is currently trading -10.22% below one month high and is +4.87% above of the lowest during that time. Looking into the simple moving average, Ironwood Pharmaceuticals Inc (IRWD)’s stock stands at a SMA-50 of $12.02 while that of 5-day is reading $8.53.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and IRWD’s SMA-200 as of now is $10.60.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.17 for the stock.
Ironwood Pharmaceuticals Inc Earnings – What Happened With IRWD
Coming around sales and income figures on IRWD Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Ironwood Pharmaceuticals Inc (IRWD) last released financial results for the quarter that ended 12/30/2023, posting a surprise factor of -104.80% for net revenue.
IRWD – Ironwood Pharmaceuticals Inc Stock Earnings Estimates
The perspective of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)’s current quarter earnings identifies that analysts are in consensus over the estimate of 0.21 for stock’s EPS in the current quarter. 5 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was -0.01.
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 156.35 million. IRWD does have institutional investors; and they hold 107.31% of the stock.
Ironwood Pharmaceuticals Inc – Insider Activity and Holdings
As on Dec 30, 2023, Blackrock Inc. was the top most holder in Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) with an ownership of 25.98 million shares of the company or 16.60% of the stake worth $223.69 million. The filing also reveals Sarissa Capital Management, LP as the second largest holder in the company with a control over 10.47% of the outstanding shares. Its stake is worth $141.12 million for having 16.39 million shares in hand.
Vanguard Group Inc also came holding a key position in the company during the recent quarter and it now holds 10.24% of the outstanding shares. With this there are now 366 institutions which have possession in IRWD’s shares.
Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.17 for the stock.
Technical Analysis of Ironwood Pharmaceuticals Inc (NASDAQ:IRWD) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Ironwood Pharmaceuticals Inc (IRWD), we notice that the stock’s 20-day average volume is at 6,043,795 shares and 100% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 50% are spotting the stock at Buy with its 50-day average volume of 5,257,406 shares. And to end, IRWD’s 100-day average volume is 3,838,467 shares with 50% of the long-term indicators pointing towards Sell for the stock.
